Diagnoptics
@diagnoptics.com
Welcome to the front line of preventive care. We stand with health professionals who are ready to fight the silent damage caused by Advanced Glycation End products (AGEs) and who believe in acting before symptoms appear. Our Solutions .cls-1{fill:#aed0d6;} Our mission We’re on a relentless mission to put AGEs at heart of preventive care For […]
Diagnoptics's Company Logos
Diagnoptics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#B51E30
Cardinal
181, 30, 48
353, 72, 41
0, 83, 73, 29
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#054B5E
Teal Blue
5, 75, 94
193, 90, 19
95, 20, 0, 63
About Diagnoptics
Diagnoptics is a pioneering medical technology company based in Groningen, the Netherlands, recognized for its innovative diagnostic devices that enable non-invasive assessment of diabetes and cardiovascular risks. Founded in 2003 by Dr. Smit and Dr.
Graaff, the company developed the AGE Reader, a state-of-the-art device capable of measuring Advanced Glycation Endproducts (AGEs) in skin tissue in just 12 seconds. AGEs serve as critical biomarkers for metabolic stress and are linked to various age-related diseases, helping clinicians predict cardiovascular complications and diabetes-related issues. Diagnoptics is committed to enhancing clinical practices by providing advanced technology for assessing tissue glycation.
The company's products, including the AGE Reader and the AGE Scanner, have received approvals across Europe, Japan, South Korea, and other regions, establishing a significant global presence. With a mission to improve care standards in diabetes and cardiovascular health, Diagnoptics continues to lead the way in innovative diagnostics that empower healthcare professionals
Company type
Privately Held
Year founded
2003
Company size
11-50 employees
